EUVIMEDEUVIMED entdecken
Crossref

Finding Potential Drug Targets for Pre‐Eclampsia Using Mendelian Randomisation and Colocalisation Analysis

Yuexin Xu, Yingzi Pan, Chengqian Wu, Tingting Zhao, Jiayan Miao, Xiaohong Ji iD

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Yuexin Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, C…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Blood Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pre‐eclampsia (PE) is a common complication of pregnancy and there is an urgent need for new drug targets. We performed whole proteome‐wide Mendelian randomisation (MR) and colocalisation analyses to identify potential therapeutic targets for PE. Material and Methods A two‐sample MR study was conducted using summary‐level statistics of 734 plasma proteins retrieved from large genome‐proteome‐wide association studies. The summary statistics of PE or eclampsia were obtained from the FinnGen consortium. Wald ratio and Inverse variance weighted (IVW) were used to assess the causal association between proteins and PE. Colocalisation analyses were conducted to examine whether the identified proteins and PE shared incidental variants.

Results

Genetically predicted circulating levels of 42 proteins were associated with PE risk after Benjamini‐Hochberg correction. Nineteen of the gene‐predicted proteins showed evidence of increased PE risk (CRELD1, CPA4, AHSG, NFASC, QDPR, NTM, PZP, FAM171B, RTN4R, FLRT2, ADH4, ADM, SPINK5, LGALS4, CKM, SPON2, UROS, CXCL10 and APOBEC3G); 23 proteins reduced the risk of PE (CLIC5, NEO1, SWAP70, KLK8, VWA2, FSTL1, CXCL11, APOB, NPPB, CNTN4, IL12B, ACHE, TCN1, GFRA2, GNMT, HPGDS, DPT, MANBA, SPARCL1, ACE, FUT8, BST1 and ACP1). Bayesian colocalisation indicated that six proteins (VWA2, ACHE, CXCL10, PZP, AHSG and UROS) and PE, which were identified as high evidence of colocalisation with PE.

Conclusions

This study provides evidence of the causal association between genetically predicted 42 proteins associated with PE risk, which might be promising drug targets for PE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaBlood ProteinsHumansFemalePregnancyMendelian Randomization AnalysisGenome-Wide Association StudyProteomeGenetic Predisposition to DiseasePolymorphism, Single Nucleotide

Stichwörter der Autor:innen

drug targetmendelian randomisationpre‐eclampsiaprotein

Substanzen

Blood ProteinsProteome

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China.

ORCID-Profile: Xiaohong Ji

Zitieren

APA

Xu, Y., Pan, Y., Wu, C., Zhao, T., Miao, J., & Ji, X. (2025). Finding Potential Drug Targets for Pre‐Eclampsia Using Mendelian Randomisation and Colocalisation Analysis. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70063

Vancouver

Xu Y, Pan Y, Wu C, Zhao T, Miao J, Ji X. Finding Potential Drug Targets for Pre‐Eclampsia Using Mendelian Randomisation and Colocalisation Analysis. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70063

BibTeX
@article{Xu2025,
  author = {Xu, Yuexin and Pan, Yingzi and Wu, Chengqian and Zhao, Tingting and Miao, Jiayan and Ji, Xiaohong},
  title = {Finding Potential Drug Targets for Pre‐Eclampsia Using Mendelian Randomisation and Colocalisation Analysis},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70063}
}
Kostenlos starten →